jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
oftan a-pant silmävoide
santen oy - dexpanthenol, retinol palmitate - silmävoide - retinoli
oftan dexa 1 mg/g silmävoide
santen oy - dexamethasone - silmävoide - 1 mg/g - deksametasoni
oftan dexa-chlora silmävoide
santen oy - chloramphenicol, dexamethasone - silmävoide - deksametasoni ja mikrobilääkkeet
lastin 0.5 mg/ml silmätipat, liuos
viatris oy - azelastine hydrochloride - silmätipat, liuos - 0.5 mg/ml - atselastiini
cleari 0.12 mg/ml silmätipat, liuos
elara pharmaservices europe limited - naphazoline hydrochloride - silmätipat, liuos - 0.12 mg/ml - nafatsoliini
oftan chlora 10 mg/g silmävoide
santen oy - chloramphenicol - silmävoide - 10 mg/g - kloramfenikoli
cosopt sine 20 mg/ml + 5 mg/ml silmätipat, liuos
santen oy - timolol maleate, dorzolamide hydrochloride - silmätipat, liuos - 20 mg/ml + 5 mg/ml - timololi
taflotan sine 15 mikrog/ml silmätipat, liuos
santen oy - tafluprost - silmätipat, liuos - 15 mikrog/ml - tafluprosti